Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q1 FY2021 Earnings Presentation
34 slides from Apollo Hospitals Enterprise's earnings presentation, Sep 14, 2020
Slide 1: Q1 FY 2021 Earnings Update
Q1 FY 2021 Earnings Update 9/14/2020 www.apollohospitals.com 1
Slide 2: Safe Harbour
SAFE HARBOUR • No representation or warranty, express or implied, is made as to, and no additional information. These are not to be construed as being provided reliance should be placed on, the fairness, accuracy, completeness or under any legal or regulatory requirements. The accuracy of these numb
Slide 3: Contents
Contents OPERATIONAL UPDATE ON APOLLO’S FIGHT STANDALONE CONSOLIDATED OPERATIONAL AHLL & PERFORMANCE AGAINST COVID HIGHLIGHTS FINANCIAL FINANCIAL PERFORMANCE GLENEAGLES – STANDALONE - 19 PERFORMANCE PERFORMANCE – HOSPITALS KOLKATA PHARMACY 3 9/14/2020 www.apollohospitals.com 3
Slide 4: COVID-19 Havoc continues
COVID-19 Havoc continues….. COVID CASES - WORLDWIDE COVID CASES - INDIA 4.5 3.9 4.0 3.5 30,34,887.0 Number of cases (Millions) 3.0 2.5 2.0 1.5 1.0 0.8 0.5 0 0.0 Deceased Active Recovered Confirmed 4 9/14/2020 www.apollohospitals.com 4
Slide 5: Apollo's response to Covid
Apollo’s response to Covid Prevention RESPONSE Early Rehabilitation diagnosis Treatment Quarantine 5 9/14/2020 www.apollohospitals.com 5
Slide 6: Project Kavach - integrated plan to tackle Covid-19
Project Kavach - an integrated and holistic plan to tackle Covid-19 INFORMATION EDUCATION TELEMEDICINE INFORMATION & ROUND THE CLOCK HELPLINE Apollo 24/7 COVID-19 SCAN AWARENESS DATA COLLECTION FOR ACTION AND FUTURE • 1860-500-1066 • Online Doctors’ consultation • COVID risk assessment tool • Credib
Slide 7: Covid Testing and Treatment
Covid Testing and Treatment 2,250+ 150,000+ 12,000+ 6,500+ 5,000+ Dedicated beds Tests Admissions Home care Stay I ‘Project Stay I’ saw success with over 50,000 room nights, helping 1 million COVID-19 positive patients, and preventing over 5 million infections. Setup Fever Clinics in 30 locations ac
Slide 8: Apollo: Best in Class Covid Clinical Outcomes
Apollo : Best in Class Covid Clinical Outcomes Sickest Outcomes a Go to place patients benchmark for covid with management multiple co- for the morbidities country MORTALITY RATES COMORBIDITIES IN DEATH CASES 0.35% below 50 yrs age 3 or more comorbidities 40% 0.76% between 50 & 60 yrs of age 2 comor
Slide 9: Covid Rehabilitation & Post Care
Covid Rehabilation & Post Care RESIDUAL COVID CONDITIONS COMORBIDITIES GETTING BACK TO NORMAL PHYSICAL MENTAL 9 9/14/2020 www.apollohospitals.com 9
Slide 10: Apollo Publications: Handbooks & Guidelines
Apollo Publications …. Setting norms and protocols Handbooks & Guidelines • Comprehensive response plan on precautions, testing, treatment at Apollo • Protocols for treatment and testing – TG Nursing homes, referral clinicians • Apollo employee Handbook • Protocols to be followed after lockdown 10 9
Slide 11: Highlights
HIGHLIGHTS 11 9/14/2020 www.apollohospitals.com 11
Slide 12: Highlights
Highlights Q1 FY21 Consolidated Revenues of ` 21,715 mio (decline of 16% yoy) Q1 FY21 Consolidated EBITDA (Pre Ind AS 116) loss of ` (427) mio Financial New Hospitals (excluding Proton) reported an EBITDA loss of ` (325) mio in Q1 FY21 as compared to an EBITDA of ` 213 mio in Performance Q1 FY
Slide 13: Highlights
Highlights 70 hospitals with total bed capacity of 10,197 beds as on Jun 30, 2020 44 owned hospitals including JVs/ Subsidiaries and Associates with 8,816 beds Capacity 11 Day care/ short surgical stay centres with 270 beds and 10 Cradles with 260 beds. 5 Managed hospitals with 851 beds. O
Slide 14: Ind AS 116 Impact Analysis
IND AS 116 IMPACT ANALYSIS 14 9/14/2020 www.apollohospitals.com 14
Slide 15: Impact on P&L and Balance Sheet – Q1FY21
Impact on P&L and Balance Sheet – Q1FY21 (` mio) Ind AS 116 was effective 1st April 2019 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use 12,700 Revenue - Right of use 16,155 Revenue - Asset Asset Other expense
Slide 16: Standalone Financial Performance
STANDALONE FINANCIAL PERFORMANCE 16 9/14/2020 www.apollohospitals.com 16
Slide 17: Standalone Financial Performance – Total
Standalone Financial Performance – Total (` mio) Q1 FY 20 Q1 FY 21 yoy (%) Revenue 22,292 19,615 -12.0% Operative Expenses 11,631 11,703 0.6% Key Highlights Employee Expenses 3,528 3,768 6.8% Q1 FY21 Revenues of ` 19,615 mio, Administrative & Other Expenses 3,875 3,730 -3.7% 12.0% yoy degrowth Total
Slide 18: Standalone Financial Performance – Mature & New Breakup
Standalone Financial Performance – Mature & New Breakup (` mio) Healthcare Healthcare Key Highlights Services New Services SAP Standalone (Mature) Hospitals Proton (Total) Hospitals 21 10 1 32 Health Care Services revenue degrew Operating beds 3,119 1,482 53 4,654 by 41.8% from ` 11,724 mio in Q1 FY
Slide 19: Standalone Financial Performance – Segment Reporting
Standalone Financial Performance – Segment Reporting (` mio) Q1 FY 20 Q1 FY 21 yoy (%) Key Highlights Revenues from each segment Healthcare Services* 11,726 6,824 -41.8% Q1 FY21 Healthcare services Stand-alone Pharmacy 10,568 12,791 21.0% Revenues at ` 6,824 mio, degrowth of 41.8% Total 22,294 19,61
Slide 20: Consolidated Financial Performance
CONSOLIDATED FINANCIAL PERFORMANCE 20 9/14/2020 www.apollohospitals.com 20
Slide 21: Consolidated Financial Performance - Total
Consolidated Financial Performance - Total (` mio) 1 of 2 Q1 FY 20 Q1 FY 21 yoy (%) Key Highlights Total Revenues 25,719 21,715 -15.6% EBITDA (Pre Ind AS 116) 2,946 -427 -114.5% Revenue degrowth of 15.6% from ` 25,719 mio in Q1 FY20 to ` 21,715 margin (%) 11.5% -2.0% -1342 bps mio in Q1 FY21 EBITDA
Slide 22: Consolidated Financial Performance – Mature & New Breakup – Total
Consolidated Financial Performance – Mature & New Breakup – Total (` mio) 2 of 2 Healthcare Healthcare Healthcare Serv Serv Group Proton Serv SAP AHLL Consol Key Highlights Group Group (New & (Mature) (Total) Others) Mature hospitals revenue degrew by Hospitals 30 13 1 44 47.4% from ` 10,320 mio in
Slide 23: Operational Performance Hospitals
OPERATIONAL PERFORMANCE HOSPITALS 23 9/14/2020 www.apollohospitals.com 23
Slide 24: Operational Performance – Hospitals (1/2)
Operational Performance – Hospitals (1/2) (` mio) Tamilnadu Region AP, Telengana Region Total (8) (Chennai & others) (1) (Hyderabad & others) (2) Particulars Q1 FY 20 Q1 FY 21 yoy (%) Q1 FY 20 Q1 FY 21 yoy (%) Q1 FY 20 Q1 FY 21 yoy (%) No. of Operating beds 7,348 7,267 2,161 1,926 1,344 1,344 Inpati
Slide 25: Operational Performance – Hospitals (2/2)
Operational Performance – Hospitals (2/2) (` mio) Karnataka Region Significant Subs/JVs/associates Others (4) (5) (Bangalore & others) (3) Particulars Q1 FY 20 Q1 FY 21 yoy (%) Q1 FY 20 Q1 FY 21 yoy (%) Q1 FY 20 Q1 FY 21 yoy (%) No. of Operating beds 770 810 910 962 2,163 2,225 Inpatient volume 13,8
Slide 26: Operational Performance Standalone Pharmacy
OPERATIONAL PERFORMANCE STANDALONE PHARMACY 26 9/14/2020 www.apollohospitals.com 26
Slide 27: Operational Performance – Standalone Pharmacy
Operational Performance – Standalone Pharmacy (` mio) Batch Particulars Q1 FY 20 Q1 FY 21 yoy (%) Key Highlights No of Stores 1100 1072 Q1 FY21 Revenues at ` 12,791 mio, growth Revenue/store 3.96 4.24 7.0% of 21.0% Upto FY 12 Batch EBITDA /store 0.33 0.37 12.0% EBITDA Margin % 8.3% 8.7% 39 bps Q1 FY
Slide 28: Update on Apollo Health & Lifestyle & Gleneagles Kolkata
UPDATE ON APOLLO HEALTH & LIFESTYLE & GLENEAGLES KOLKATA 28 9/14/2020 www.apollohospitals.com 28
Slide 29: Update on AHLL
Update on AHLL (` mio) Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) Key Highlights Network 145 637 23 61 50 8 7 11 Footfalls/Day* 649 3843 195 43 817 34 8 19 AHLL reported EBITDA loss of Gross ARPP (Rs.)* 1748 648 2329 4488 1379 103751 26430 88407 ` (191) mio as compared t
Slide 30: Update on Gleneagles Kolkata
Update on Gleneagles Kolkata (` mio) Key Highlights Apollo Gleneagles Kolkata Particulars Q1 FY 20 Q1 FY 21 yoy (%) Apollo Gleneagles Kolkata reported Revenue of Revenue 1,143 512 -55.2% ` 512 mio in Q1 FY21, degrowth of 55% EBITDA (Pre Ind AS 116) 156 -250 EBITDA (Pre Ind AS 116) loss of ` (250) mi
Slide 31: www.apollohospitals.com
31 9/14/2020 www.apollohospitals.com 31
Slide 32: Appendix: Basis of Consolidation
Appendix: Basis of Consolidation AHEL AHEL AHEL Standalone Location Description Subsidiaries Location Description Ownership Ownership Samudra Healthcare Enterprises Ltd. Kakinada Hospital 100.00% Chennai Main Chennai Hospital Apollo Hospitals (UK) Ltd UK Hospital 100.00% ACI - Chennai Chennai Hospit
Slide 33: Hospitals – Understanding Key Operating Metrics
Hospitals – Understanding Key Operating Metrics Description Formula / Calculation Key Driver Operating Beds • Number of operating beds • Project execution • Capital Expenditure Occupancy • In-patient Bed Days • In-patient Bed Days Billed • Brand • Doctor reputation • Quality of outcomes • Competitio
Slide 34: Thank You
THANK YOU 34 9/14/2020 www.apollohospitals.com 34
Apollo Hospitals Enterprise — Q1 FY2021 Earnings Presentation on 6ix